Literature DB >> 22590666

The 7th lung cancer TNM classification and staging system: Review of the changes and implications.

Saeed Mirsadraee1, Dilip Oswal, Yalda Alizadeh, Andrea Caulo, Edwin van Beek.   

Abstract

Lung cancer is the most common cause of death from cancer in males, accounting for more than 1.4 million deaths in 2008. It is a growing concern in China, Asia and Africa as well. Accurate staging of the disease is an important part of the management as it provides estimation of patient's prognosis and identifies treatment sterategies. It also helps to build a database for future staging projects. A major revision of lung cancer staging has been announced with effect from January 2010. The new classification is based on a larger surgical and non-surgical cohort of patients, and thus more accurate in terms of outcome prediction compared to the previous classification. There are several original papers regarding this new classification which give comprehensive description of the methodology, the changes in the staging and the statistical analysis. This overview is a simplified description of the changes in the new classification and their potential impact on patients' treatment and prognosis.

Entities:  

Keywords:  Lung cancer staging; Lung neoplasms; Neoplasm staging

Year:  2012        PMID: 22590666      PMCID: PMC3351680          DOI: 10.4329/wjr.v4.i4.128

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  16 in total

1.  Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging.

Authors:  R C Rintoul; K M Skwarski; J T Murchison; W A Wallace; W S Walker; I D Penman
Journal:  Eur Respir J       Date:  2005-03       Impact factor: 16.671

2.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

3.  The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.

Authors:  Patti A Groome; Vanessa Bolejack; John J Crowley; Catherine Kennedy; Mark Krasnik; Leslie H Sobin; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

4.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

5.  The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.

Authors:  Frances A Shepherd; John Crowley; Paul Van Houtte; Pieter E Postmus; Desmond Carney; Kari Chansky; Zeba Shaikh; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-12       Impact factor: 15.609

6.  Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung.

Authors:  W P Luke; F G Pearson; T R Todd; G A Patterson; J D Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1986-01       Impact factor: 5.209

Review 7.  The revised TNM staging system for lung cancer.

Authors:  Ramon Rami-Porta; John J Crowley; Peter Goldstraw
Journal:  Ann Thorac Cardiovasc Surg       Date:  2009-02       Impact factor: 1.520

8.  The value of mediastinal staging with endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer.

Authors:  Henrik Ømark Petersen; Jens Eckardt; Ardeshir Hakami; Karen Ege Olsen; Ole Dan Jørgensen
Journal:  Eur J Cardiothorac Surg       Date:  2009-06-06       Impact factor: 4.191

9.  Minimally invasive endoscopic staging of suspected lung cancer.

Authors:  Michael B Wallace; Jorge M S Pascual; Massimo Raimondo; Timothy A Woodward; Barbara L McComb; Julia E Crook; Margaret M Johnson; Mohammad A Al-Haddad; Seth A Gross; Surakit Pungpapong; Joy N Hardee; John A Odell
Journal:  JAMA       Date:  2008-02-06       Impact factor: 56.272

10.  Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer.

Authors:  M Coughlin; J Deslauriers; M Beaulieu; B Fournier; M Piraux; J Rouleau; A Tardif
Journal:  Ann Thorac Surg       Date:  1985-12       Impact factor: 4.330

View more
  93 in total

1.  TNM staging update for lung cancer: Why is this important?

Authors:  John T Murchison
Journal:  World J Radiol       Date:  2012-04-28

Review 2.  The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications.

Authors:  Wanyin Lim; Carole A Ridge; Andrew G Nicholson; Saeed Mirsadraee
Journal:  Quant Imaging Med Surg       Date:  2018-08

3.  Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?

Authors:  Ahsan S Farooqi; Emma B Holliday; Pamela K Allen; Xiong Wei; James D Cox; Ritsuko Komaki
Journal:  Radiother Oncol       Date:  2017-01-07       Impact factor: 6.280

4.  ATS Core Curriculum 2014: part I. Adult pulmonary medicine.

Authors:  Melissa R Nyendak; David M Lewinsohn; Raj D Shah; Richard G Wunderink; Carl D Koch; Alison Morris; Kolene E McDade; Gaetane C Michaud; Amit K Mahajan; Colleen L Channick; A Christine Argento; Momen M Wahidi; William S Beckett; Gautam George; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2014-09

5.  Temporal trends in demographics and overall survival of non-small-cell lung cancer patients at Moffitt Cancer Center from 1986 to 2008.

Authors:  Matthew B Schabath; Zachary J Thompson; Jhanelle E Gray
Journal:  Cancer Control       Date:  2014-01       Impact factor: 3.302

6.  CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.

Authors:  Thibaud P Coroller; Patrick Grossmann; Ying Hou; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Gretchen Hermann; Philippe Lambin; Benjamin Haibe-Kains; Raymond H Mak; Hugo J W L Aerts
Journal:  Radiother Oncol       Date:  2015-03-04       Impact factor: 6.280

7.  TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.

Authors:  Matthew B Schabath; Anna R Giuliano; Zachary J Thompson; Ernest K Amankwah; Jhanelle E Gray; David A Fenstermacher; Kristen A Jonathan; Amer A Beg; Eric B Haura
Journal:  Carcinogenesis       Date:  2013-07-09       Impact factor: 4.944

Review 8.  Progress in the management of limited-stage small cell lung cancer.

Authors:  Arya Amini; Lauren A Byers; James W Welsh; Ritsuko U Komaki
Journal:  Cancer       Date:  2013-12-10       Impact factor: 6.860

9.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

10.  Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer.

Authors:  Li-Li Deng; Hong-Bin Deng; Chang-Lian Lu; Yang Guo; Di Wang; Chun-Hua Yan; Xing Lv; Yu-Xia Shao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-04       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.